Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2004
12/30/2004US20040267002 Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of listeria monocytogenes
12/30/2004US20040266714 Modulate gene expression; diagnosis, therapy of disease; antidiabetic agents; insulin resistance
12/30/2004US20040266713 Using nucleic acids; antitumor agents
12/30/2004US20040266710 Immunotherapy; induce immunology response
12/30/2004US20040266709 Immunotherapy; induction immunology response
12/30/2004US20040266706 Cross-linked oligomeric compounds and their use in gene modulation
12/30/2004US20040265999 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
12/30/2004US20040265974 Human chemokine polypeptides
12/30/2004US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases
12/30/2004US20040265969 Reverse polymerases; kits; electrophoresis
12/30/2004US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same
12/30/2004US20040265963 Inhibitory peptide for use in treatment and prevention of nervous system, connective tissue, autoimmune, inflammatory and cell proliferative disorders
12/30/2004US20040265955 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
12/30/2004US20040265954 Transgenic escherichia for use in the expression and propagation of N-glycosylated target proteins; bioreactors and heterologous protein expression
12/30/2004US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents
12/30/2004US20040265876 Isolated polynucleotide associated with Type II diabetes mellitus and methods of use thereof
12/30/2004US20040265873 primer which specifically amplifies groEL2 gene; efficiently identify Streptomyces species; identifying a potato scab pathogenic microorganism using a new chronometer molecule as a target gene; groEL2 gene encodes a stress-related protein in bacteria whose function is well conserved
12/30/2004US20040265870 amino-reactive nucleotides such as aminoallyl-dUTP or aminohexyl-dATP for synthesis
12/30/2004US20040265867 the Riley-Day syndrome; localization will permit prenatal diagnosis in affected families
12/30/2004US20040265866 Receptor on the surface of activated T-cells: ACT-4
12/30/2004US20040265858 Sets of generalized target-binding e-tag probes
12/30/2004US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
12/30/2004US20040265852 Diangnosis and treatment of AUR1 and/or AUR2 related disorders
12/30/2004US20040265849 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening
12/30/2004US20040265846 Screening point mutations to diagnose cardiovascular diseases, psychiatric diseases, or cancer; binding proteins; monoclonal antibodies; kits
12/30/2004US20040265835 Fluorescence activated cell-sorting; liposomes; phospholipid mimics
12/30/2004US20040265834 Antibodies; host cells; membrane proteins; for treatment of carcinoma, rheumatoid arthritis, asthma, kidney or testis related carcinoma, and neuron diseases
12/30/2004US20040265833 Such as carcinomas, adenomas, and polyps; peptide nucleic acids; solid phase synthesis; microarrays; kits
12/30/2004US20040265832 Genotyping short terminal repeats/markers; statistical analysis; drug screening
12/30/2004US20040265802 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
12/30/2004US20040265796 Methods and kits for detecting SARS-associated coronavirus
12/30/2004US20040265786 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
12/30/2004US20040265324 Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines
12/29/2004WO2004113872A2 Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces
12/29/2004WO2004113564A1 Method for investigating cytosine methylation in dna sequences by means of triplex-forming oligomers
12/29/2004WO2004113554A2 Methods for determining susceptibility to psoriasis
12/29/2004WO2004113553A2 Method of producing pure amidites and oligonucleotides
12/29/2004WO2004113521A1 New biological entities and the use thereof
12/29/2004WO2004113511A2 Cell line and uses thereof
12/29/2004WO2004113501A2 Methods and compositions relating to lipid accumulation
12/29/2004WO2004113500A2 B7s1: an immune modulator
12/29/2004WO2004113497A2 Gene delivery to tumors
12/29/2004WO2004113495A2 Rna-based transcriptional regulators
12/29/2004WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/29/2004WO2004113361A2 Novel prokineticin receptor isoforms and methods of use
12/29/2004WO2004112706A2 Vaccines, immunotherapeutics and methods for using the same
12/29/2004WO2004112703A2 Interleukin-21 analogs
12/29/2004WO2004112570A2 Detection of survivin in the biological fluids of cancer patients
12/29/2004WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004WO2004093790A3 Yeast ectopically expressing abnormally processed proteins and uses therefor
12/29/2004WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004WO2004074300A3 Novel photolabile protective groups for improved processes to prepare oligonucleotide arrays
12/29/2004WO2004072244A3 Polymerase-based protocols for generating chimeric oligonucleotides
12/29/2004WO2004053061A3 Methods of therapy and diagnosis using targeting of cells that express lax
12/29/2004WO2004039309A3 Dc-sign isoforms, related compositions and methods for their use in disease therapy
12/29/2004EP1491591A1 New fluorescence cyanine labels containing a sulfamido linker arm
12/29/2004EP1491217A1 Stabilization of polynucleotide complexes
12/29/2004EP1490515A1 Chloral-free dca in oligonucleotide synthesis
12/29/2004EP1490511A2 Methods and systems for dynamic gene expression profiling
12/29/2004EP1490490A2 Antisense iap nucleobase oligomers and uses thereof
12/29/2004EP1490488A2 Purification methods for oligonucleotides and their analogs
12/29/2004EP1490486A2 Method of identifying genes controlling diferentiation
12/29/2004EP1490484A2 Further bmp-2 inducible kinases and the uses thereof
12/29/2004EP1490385A2 Jagged 2 inhibitors for inducing apoptosis
12/29/2004EP1490384A2 A building block forming a c-c bond upon reaction
12/29/2004EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004EP1117808B1 Transformation system in the field of filamentous fungal hosts: in chrysosporium
12/29/2004EP0898575B1 A combinatorial protecting group strategy for multifunctional molecules
12/29/2004EP0785946B1 Materials for the production of nanometer structures and use thereof
12/29/2004EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004CN1558914A Receptor, the use thereof, and mouse antibodies
12/29/2004CN1558207A Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
12/29/2004CN1557827A Gene associated with schizophrenia and polymorphism site and use thereof
12/29/2004CN1182252C Prepn. of double-stranded nucleic acid on surface of solid support
12/29/2004CA2529882A1 Cell line and uses thereof
12/29/2004CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions
12/29/2004CA2529639A1 Detection of survivin in the biological fluids of cancer patients
12/29/2004CA2529520A1 Interleukin-21 analogs
12/29/2004CA2529051A1 Vaccines, immunotherapeutics and methods for using the same
12/29/2004CA2526648A1 Method for producing a synthetic gene or other dna sequence
12/29/2004CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/28/2004US6835827 Labelled oligonucleotides synthesized on solid-supports
12/28/2004US6835826 Acid resistance, stability; telomerase inhibitor
12/28/2004US6835825 For regulating activation/development/differentiation of hematopoietic cells
12/23/2004WO2004111220A1 Proteases
12/23/2004WO2004111217A2 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
12/23/2004WO2004111200A2 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer
12/23/2004WO2004111191A2 Methods and compositions for controlling efficacy of rna silencing
12/23/2004WO2004111190A2 IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES
12/23/2004WO2004111075A2 Alternative reading frame polypeptides for treatment
12/23/2004WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide
12/23/2004WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
12/23/2004WO2004110371A2 Method for the treatment of malignancies
12/23/2004WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/23/2004WO2004110345A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
12/23/2004WO2004110246A2 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns
12/23/2004WO2004097039A9 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
12/23/2004WO2004083386A3 Methods of making repetitive sequences removed probes and use thereof
12/23/2004WO2004074439A9 An expression cassette and vector for transient or stable expression of exogenous molecules